BCRX
BioCryst Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.48 / 10
Underperform
Technically, BCRX is under pressure: the aggregate score of 2.48/10 signals a weak structure, dominated by bearish indicators including MACD Golden Cross and Long Upper Shadow. The scarcity of bullish signals and the persistent downward momentum underscore the need for caution and highlight potential downside risk in the near term.
Analysis Checks(0/3)
Long Upper Shadow
Score2.62/10
Win Rate42.86%
Hist. Signals14
Avg Return0.31%
Score2.62/10
Win Rate42.86%
Hist. Signals14
Avg Return0.31%
MACD Golden Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-2.38%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-2.38%
MACD Death Cross
Score3.83/10
Win Rate50.00%
Hist. Signals10
Avg Return0.33%
Score3.83/10
Win Rate50.00%
Hist. Signals10
Avg Return0.33%
Long Upper Shadow
Score2.62/10
Win Rate42.86%
Hist. Signals14
Avg Return0.31%
Score2.62/10
Win Rate42.86%
Hist. Signals14
Avg Return0.31%
MACD Death Cross
Score3.83/10
Win Rate50.00%
Hist. Signals10
Avg Return0.33%
Score3.83/10
Win Rate50.00%
Hist. Signals10
Avg Return0.33%
MACD Golden Cross
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-2.38%
Score1/10
Win Rate25.00%
Hist. Signals8
Avg Return-2.38%
What is the current technical signals for BCRX?
- BCRX presents a Underperform setup with a Technical Score of 2.48/10. Key technical indicators highlight an RSI of 37.22 and a MACD of -0.06, with the trend anchored by the 50-Day SMA at 7.20. Traders should monitor key support at 6.12 and resistance at 6.46.
